If you made any changes in Pure these will be visible here soon.

Research Output 1992 2018

Filter
Poster
2017

Escalated dose somatostatin analogues (SSAs) in management of neuroendocrine tumors (NETs): A systematic review

Chan, D., Ferone, D., Albertelli, M., Segelov, E. & Singh, S. 2017

Research output: Contribution to conferencePosterOther

Optimising follow up after complete surgical resection of Gastrointestinal Neuroendocrine Tumours- a Delphi process to produce expert consensus in an area lacking clinical evidence

Moody, L., Segelov, E., Chan, D., Strosberg, J. R., Metz, D. & Singh, S. 2017 1 p.

Research output: Contribution to conferencePosterOther

2016

CommNETS: Formation of an International Commonwealth countries NET partnership

Singh, S., Lawrence, B., Chan, D., Pavlakis, N. & Segelov, E. 2016 p. 120 1 p.

Research output: Contribution to conferencePosterOther

Identifying and Prioritising Gaps in Neuroendocrine Tumour Research-results of the Delphi Consensus Project of the Commonwealth Neuroendocrine Tumour Research Collaboration (CommNETS)

Segelov, E., Chan, D., Harris-Roxas, B., Lawrence, B., Pavlakis, N., Kennecke, H., Jackson, C., Law, C. & Singh, S. 2016 p. 120 1 p.

Research output: Contribution to conferencePosterOther

Indications for, and impact of oncotype DX on adjuvant treatment recommendations when third party funding is unavailable

Chin-Lenn, L., Segelov, E., De Boer, R., Marx, G. M., Hughes, T., McCarthy, N., White, S. C., Foo, S. L., Rutovitz, J., Della-Fiorentina, S., Jennens, R. R., Antill, Y., Tsoi, D., Cronk, M., Lombard, J. M., Kiely, B., Chirgwin, J. & Bruce Mann, G. 2016

Research output: Contribution to conferencePosterOther

Optimal follow-up strategy for resected neuroendocrine tumours: a systematic review

Patel, D., Chan, D., Moody, L., Metz, D., Strosberg, J. R., Segelov, E. & Singh, S. 2016

Research output: Contribution to conferencePosterOther

Open Access

Use of chemotherapy and mismatch repair deficiency testing in resected stage II colon cancer

Au, L., Grant, M., Haydon, A., Oliva, K., Wilkins, S. T., Segelov, E., Antill, Y., Peter, C., Ranchod, P., Chin, M., Skinner, S., Wale, R., McMurrick, P. & Shapiro, J. 2016

Research output: Contribution to conferencePosterOther

Open Access
2015

InterAACT: An International Multicentre Open Label Randomised Phase II Advanced Anal Cancer Trial Comparing Cisplatin (CDDP) plus 5-fluorouracil (5-FU) versus Carboplatin (CBDCA) plus Weekly Paclitaxel (PTX) in Patients with Inoperable Locally Recurrent (ILR) or Metastatic Disease

Scalafini , F., Adams, R. A., Eng, C., Benson III, A., Glynne-Jones, R., Montefiori, D. C., Arnold, D., Roy, A. C., Guren, . M. G., Segelov, E., Seymour, M. T., Bryant, A., Peckitt, C., Cunningham, D. & Bridgewater, J. A. 2015 1 p.

Research output: Contribution to conferencePosterOther

Physical activity for women with metastatic breast cancer: a feasibility study

Yee, J., Davis, G. M., Hackett, D., Beith, J. M., Wilcken, N., Currow, D., Emery, J., Phillips, J., Martin, A., Hui, R., Harrison, M., Segelov, E. & Kilbreath, S. L. 1 May 2015 p. 464 1 p.

Research output: Contribution to conferencePosterOther

TOPS: A randomised controlled trial of a multidisciplinary intervention for post-cancer fatigue

Sandler, C., Goldstein, D., Horsefield, S., Bennett, B. K., Friedlander, M., Bastick, P. A., Lewis, C. R., Segelov, E., Boyle, F. M., Chin, M. T. M., Barry, B. K., Webber, K. & Lloyd, A. R. 2015 p. 9571 1 p.

Research output: Contribution to conferencePosterOther

2014

A multi-centre, phase II, open-label, single arm study of panitumumab, cisplatin and gemcitabine in biliary tract cancer: Primary results of the AGITG TACTIC study

Shannon, J., Goldstein, D., Wong, N., Chinchen, S., Sjoquist, K. M., O'Connell, R., Grimison, P., McLachlan, S-A., Tebbutt, N., Lipton, L. R., Vasey, P., Cronk, M., Varma, S., Jefford, M. J., Segelov, E., Abdi, E. A., Ng, S., Karapetis, C., Gebski, V. J. & Zalcberg, J. 2014 p. 244 1 p.

Research output: Contribution to conferencePosterOtherpeer-review

Comparable morbidity, mortality and patient long-term survival can be achieved in patients with colorectal liver metastases undergoing 2 stage or downstaging liver resections to patients undergoing routine resections

Ip, E., Bergamin, P., Wong, J., Goldstein, D., Segelov, E., Aghmesheh , K. & Haghighi, K. 1 Mar 2014 p. 145 1 p.

Research output: Contribution to conferencePosterOther

Impact of chemotherapy partner on efficacy of targeted therapy in metastatic colorectal cancer (mCRC): A meta-analysis

Chan, D., Pavlakis, N., Shapiro, J., Price, T. J., Karapetis, C., Tebbutt, N. & Segelov, E. 2014 1 p.

Research output: Contribution to conferencePosterOther

Meta-analysis of outcomes of VEGF and EGFR targeted biologic therapy in relapsed metastatic colorectal cancer (mCRC)

Chan, D., Segelov, E., Shapiro, J., Price, T. J., Karapetis, C., Tebbutt, N. & Pavlakis, N. 2014

Research output: Contribution to conferencePosterOther

2013

A clinical audit of anal cancer in a single tertiary centre over 10 years

Kok, P. S., Pendlebury, S., Smith, A., Jarvis, S. & Segelov, E. 2013 1 p.

Research output: Contribution to conferencePosterOther

Barriers to recruitment for a post-cancer fatigue intervention study- the TOPS trial.

Sandler, C., Webber, K., Friedlander, M., Lewis, C. R., Chin, M. T. M., Venkateswaran, R., Segelov, E., Bastick, P. A., Lynch, J., Thomas, D. & Liauw, W. S. 2013 p. 116 1 p.

Research output: Contribution to conferencePosterOther

Meta-analysis of progression free survival impact of biological therapy in relapsed metastatic colorectal cancer.

Chan, D., Segelov, E., Shapiro, J., Price, T. J., Karapetis, C., Tebbutt, N. & Pavlakis, N. 2013 p. 117 1 p.

Research output: Contribution to conferencePosterOther

Physical activity and fitness in women with metastatic breast cancer

Yee, J., Davis, G. M., Beith, J. M., Wilcken, N., Hui, R., Harrison, M., Currow, D., Emery, J., Phillips, J., Martin, A., Segelov, E. & Kilbreath, S. L. 2013 1 p.

Research output: Contribution to conferencePosterOther

The AGITG ICECREAM STUDY: The Irinotecan Cetuximab Evaluation and Cetuximab Response Evaluation Amongst Patients with a G13D Mutation

Segelov, E., Wilson, K., Gebski, V., Waring, P., Desai, J., Nott, L., Karapetis, C., Hall, M., Wasan, H. & Shapiro, J. 2013 p. 155 1 p.

Research output: Contribution to conferencePosterOther

Τhe unmet needs of cancer survivors and their preferences for discussing them with oncologists and general practitioners

Webber, K., Girgis, A., Bennett, B. K., Bonaventura, T., Boyle, F., Koh, E-S., Friedlander, M., Segelov, E. & Goldstein, D. A. 2013 1 p.

Research output: Contribution to conferencePosterOtherpeer-review

2012

Current Care And Needs Of Adult Cancer Survivors-A Cross-sectional Survey Asia Pacific

Webber, K., Girgis, A., Bennett, B. K., Bonaventura, T., Boyle, F., Koh, E-S., Friedlander, M., Segelov, E. & Goldstein, D. 1 Nov 2012 p. 356-357

Research output: Contribution to conferencePosterOther

First-in-man, Multicenter, Phase I Trial Evaluating the Safety of First-in-class Therapeutic, EGFR-targeted, Paclitaxel-Packaged Minicells

Solomon, B., Desai, J., Scott, A. M., Rosenthal, M. A., McArthur, G., Segelov, E., MacDiarmid, J. & Brahmbhatt, H. 2012 p. 179 1 p.

Research output: Contribution to conferencePosterOther

The role of human papillomaviruses in oesophageal squamous cell carcinoma: a review of the evidence

Liyanage, S., Segelov, E., Garland, S., Tabrizi, S., Seale, H., Crowe, P., Dwyer, D., Barbour, A., Newall, A., Malik, A. & MacIntyre, R. Jun 2012 p. e351 - e352 2 p.

Research output: Contribution to conferencePosterOtherpeer-review

2011

A randomised trial assessing the use of electro-acupuncture for aromatase inhibitor induced arthralgia

Beith, J. M., Segelov, E., Ormerod, K., McLean, A. & Oh, B. 2011

Research output: Contribution to conferencePosterOther

2010

Overview of current evidence for the possible aetiological role of human papillomavirus (HPV) in oesophageal squamous cell carcinoma

Segelov, E., Liyanage, S. & MacIntyre, R. 2010 p. 356-357 2 p.

Research output: Contribution to conferencePosterOther

Review of the epidemiology of oesophageal adenocarcinomas and squamous cell carcinomas. Asia Pacific J Clin Onc 6:217

Malik, A., MacIntyre, R., Segelov, E. & Liyanage, S. 9 Aug 2010

Research output: Contribution to conferencePosterOther

SCOT: Short Course Oncology Therapy - A Study of Adjuvant Chemotherapy in Colorectal Cancer

Segelov, E., Price, T. J., Jefford, M. J., Walpole, E., Yip, D., Ransom, D., Jeffrey, M., Tebbutt, N. & Wong, N. 2010

Research output: Contribution to conferencePosterOther

2009

Detecting late trastuzumab cardiotoxicity using cardiac magnetic resonance imaging

Lawley, C., McCrohon, J., Wainwright, C., Lynch, J., Beith, J. M. & Segelov, E. 2009

Research output: Contribution to conferencePosterOther

2005

Outcomes and utilization patterns of intravenous bisphosphonates for bony metastases in patients with advanced breast cancer: results in the off-trial setting

Liauw, W. S., Segelov, E., Lih, A., Links, M., Dunleavy, R. & Ward, R. L. 2005

Research output: Contribution to conferencePosterOther

1995

Characterisation of a novel cisplatin sensitive mammalian mutant cell line

Segelov, E., Mann, G. J. & Harnett, P. 1995 p. 286

Research output: Contribution to conferencePosterOther